American Society of Hematology: Older Adults With Aggressive Blood Cancer are Responsive to Treatment and Show Prolonged Survival
May 10, 2024
May 10, 2024
WASHINGTON, May 10 (TNSres) -- The American Society of Hematology issued the following news release:
Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.
AML is an aggressive and often deadly form of blood cancer that can be difficult to treat. For older adults with AML, the conventional treat . . .
Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.
AML is an aggressive and often deadly form of blood cancer that can be difficult to treat. For older adults with AML, the conventional treat . . .